Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
04/2003
04/10/2003WO2003029413A2 A novel g protein-coupled receptor, gave 10
04/10/2003WO2003029409A2 Methods for generating, selecting, and identifying compounds which bind a target molecule
04/10/2003WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003WO2003029290A1 Drug transporter and use thereof
04/10/2003WO2003029289A2 Fragements of heat shock proteins and their use
04/10/2003WO2003029286A1 Fluorescent proteins
04/10/2003WO2003028745A1 A composition for lowering the concentration of intestinal pathogenic peptides
04/10/2003WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028536A2 Methods for diagnosing and treating heart disease
04/10/2003WO2003017935A9 Human antibodies specific for interleukin 15 (il-15)
04/10/2003WO2003008575A3 Dna sequences for regulating transcription
04/10/2003WO2003002598A3 Peptides for use as translocation factors
04/10/2003WO2003000861A9 Eukaryotic genes involved in adult lifespan regulation
04/10/2003WO2002101051A3 Genes and proteins for the biosynthesis of anthramycin
04/10/2003WO2002099091A3 Endo-beta-1,4-glucanase from bacillus
04/10/2003WO2002081668A8 Desaturase genes and uses thereof
04/10/2003WO2002072826A3 Neurotrophic factors
04/10/2003WO2002063013A3 Human acid phosphatase gene
04/10/2003WO2002059311A3 Colon cancer marker
04/10/2003WO2002059297A3 A library of a collection of cells
04/10/2003WO2002059290A3 A method for evolving a cell having desired phenotype and envolved cells
04/10/2003WO2002059282A3 Adipocyte complement related protein zacrp13
04/10/2003WO2002057476A9 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa)
04/10/2003WO2002057460A3 Polynucleotides encoding human phosphatases
04/10/2003WO2002055705A3 Proteins and nucleic acids encoding same
04/10/2003WO2002050285A9 Histone deacetylase-related gene and protein
04/10/2003WO2002050122A3 Means for the diagnosis and therapy of ctcl
04/10/2003WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments
04/10/2003WO2002050104A3 Methods and cells for detecting modulators of rgs proteins
04/10/2003WO2002048338A3 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
04/10/2003WO2002046406A3 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
04/10/2003WO2002044203A3 Production of recombinant bmp-2
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002028889A3 Haemophilus influenzae antigens and corresponding dna fragments
04/10/2003WO2002026980A3 Human ion-exchanger proteins and polynucleotides encoding t he same
04/10/2003WO2002012294A3 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
04/10/2003WO2002008396A3 Human proteases
04/10/2003WO2001092547A9 Modified bovine adenovirus having altered tropism
04/10/2003WO2001083800A3 Heterologous production of polyketides
04/10/2003WO2001073014A9 Human survivin interacting protein 1 (sip-1)
04/10/2003US20030069409 T1-R ligand III
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069405 70 human secreted proteins
04/10/2003US20030069398 Identification of human gaba transporter
04/10/2003US20030069394 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression.
04/10/2003US20030069193 Has an activity against MRSA (methicillin-resistant Staphylococcus aureus).
04/10/2003US20030068808 Methods for generating antibiotic resistant microbes and novel antibiotics
04/10/2003US20030068806 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
04/10/2003US20030068791 Generation of xylitol in culture; prepare nutrient broth, inoculate with microorganism containing genes associated with pentose phosphate pathway, express gene and recover xylitol
04/10/2003US20030068789 Propagation of nitrilase producing microorganisms; prepare nutrient broth, inoculate with genetically engineered microorganism, expression vector and recover nitrilase
04/10/2003US20030068788 Nucleotide sequences coding enzymatic polypeptide for use in biological pest control
04/10/2003US20030068784 Peptide for use in the diagnosis and treatment of cardiovascular disorders
04/10/2003US20030068777 Method for detecting microorganisms and detection kit
04/10/2003US20030068690 Process for the in vitro culture of different stages of tissular parasites
04/10/2003US20030068678 WISP polypeptides and nucleic acids encoding same
04/10/2003US20030068677 Recombinant production of novel polyketides
04/10/2003US20030068673 Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2)
04/10/2003US20030068640 Diagnosing vision defects in mammals; obtain tissue sample, extract nucleotide sequences, detect mutaion in tigr allele, presence of mutation indicates vision defects
04/10/2003US20030068612 Reverse two-hybrid systems
04/10/2003US20030068611 Methods for increasing microbial metabolic efficiency through regulation of oxidative stress
04/10/2003US20030068347 Yeast biocapsules with liquid or microbially encapsultable cosmetic active ingredients
04/10/2003US20030068328 Live attenuated salmonella strains for producing monovalent or multivalent vaccines
04/10/2003US20030068323 Hybrid compositions for intracellular targeting
04/10/2003US20030068303 Biologic-chemical fungicide compositions and methods of use
04/10/2003US20030066915 Apparatus and method for rapid disruption of cells or viruses
04/10/2003CA2463404A1 Fragements of heat shock proteins and their use
04/10/2003CA2462795A1 Secreted proteins
04/10/2003CA2462790A1 Ul16 binding protein 4
04/10/2003CA2462644A1 Human and murine cytokine polypeptides
04/10/2003CA2462641A1 Whole cell engineering using real-time metabolic flux analysis
04/10/2003CA2462424A1 A novel g protein-coupled receptor, gave 10
04/10/2003CA2462119A1 Process for producing .alpha.1,4-galactosyltransferase and galactose-containing complex sugar
04/10/2003CA2462113A1 Multi-chain eukaryotic display vectors and uses thereof
04/10/2003CA2462077A1 Fluorescent proteins
04/10/2003CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003CA2461292A1 Apo-2 ligand variants and uses thereof
04/10/2003CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003CA2460396A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
04/10/2003CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003CA2460257A1 Methods for diagnosing and treating heart disease
04/10/2003CA2459133A1 Methods for generating, selecting, and identifying compounds which bind a target molecule
04/10/2003CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003CA2455225A1 Novel proteins and nucleic acids encoding same
04/09/2003EP1300471A1 Nutritional mixture and method for early identification and count of gram-negative organisms
04/09/2003EP1300468A2 TRNA synthetase
04/09/2003EP1300467A1 Novel polypeptide and dna thereof
04/09/2003EP1300463A1 Isolated nucleic acid molecules encoding SSX family members and uses thereof
04/09/2003EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation
04/09/2003EP1300156A2 Otitis media vaccine
04/09/2003EP1300082A2 Lysin of a bacteriophage of Clostridia spp
04/09/2003EP1299554A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants
04/09/2003EP1299552A2 Methods and compositions for simultaneous saccharification and fermentation
04/09/2003EP1299547A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof
04/09/2003EP1299546A2 Aminoacyl trna synthetases
04/09/2003EP1299545A2 Drug metabolizing enzymes
04/09/2003EP1299544A2 Fimh adhesin proteins and methods of use
04/09/2003EP1299540A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
04/09/2003EP1299538A2 Secreted proteins